Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.27
Delayed Data
As of Mar 29
 +0.48 / +12.66%
Today’s Change
3.71
Today|||52-Week Range
10.06
+3.39%
Year-to-Date

Today’s Trading

Previous close3.79
Today’s open3.81
Day’s range3.77 - 4.28
Volume3,087,201
Average volume (3 months)1,627,396
Market cap$518.2M
Dividend yield--
Data as of 3:59pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-38.06%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.30

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...+1.16+6.08%
CYTKCytokinetics Inc+0.05+0.40%
RETAReata Pharmaceutical...-0.17-0.74%
SPPISpectrum Pharmaceuti...+0.01+0.15%
Data as of 3:59pm ET, 03/29/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts


Search for Jobs